Identification of an Anti‐Inflammation Protein, Annexin A1, in Tendon Derived Stem Cells (TDSCs) of Cystic Fibrosis Mice: A Comparative Proteomic Analysis
- 21 May 2018
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 12 (6) , e1700162
Abstract
Purpose: A previous study reported an elevated inflammation during tendon injury in mice with cystic fibrosis (CF), indicating the inadequate management of inflammation due to dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR). The objective of this study is to identify the targets of CFTR that contribute to the abnormal inflammation during tendon injury.Experimental Design: A 2D gel electrophoresis and mass‐spectrometry‐based comparative proteomics is performed to find the molecular targets of CFTR. And the targeted protein is further confirmed at both mRNA and protein levels.Results: It is identified that 14 proteins are differentially expressed, with annexin A1 being one of the most significantly downregulated protein. Further confirmation shows that annexin A1 is significantly decreased in TDSCs isolated from DF508 mice. As an essential anti‐inflammation mediator, it is also downregulated in the injured tendon tissue of DF508 mice when compared with WT mice.Conclusions and Clinical Relevance: Decreased annexin A1 expression can contribute to the elevated inflammation in DF508 mice during tendon injury. Therefore, annexin A1 can be considered as a new potential biomarker or drug target for a possible therapeutic approach in clinical practice.Keywords
Funding Information
- Research Grants Council, University Grants Committee (14119115, 14160917, 9054014 N_CityU102/15,, T12‐402/17‐N)
- National Natural Science Foundation of China (81772404, 81371946, 81430049, 81772322)
This publication has 44 references indexed in Scilit:
- Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone DiseasePLOS ONE, 2013
- Neutrophil necrosis and annexin 1 degradation associated with airway inflammation in lung transplant recipients with cystic fibrosisBMC Pulmonary Medicine, 2012
- Annexin A1 Interaction with the FPR2/ALX ReceptorJournal of Biological Chemistry, 2012
- Multipotent mesenchymal stromal cells and the innate immune systemNature Reviews Immunology, 2012
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 2011
- Loss of Cystic Fibrosis Transmembrane Conductance Regulator Function Enhances Activation of p38 and ERK MAPKs, Increasing Interleukin-6 Synthesis in Airway Epithelial Cells Exposed to Pseudomonas aeruginosaJournal of Biological Chemistry, 2010
- Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeuticsBritish Journal of Pharmacology, 2009
- Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis MicePLOS Genetics, 2009
- Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound HealingPLOS ONE, 2008
- Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human boneThorax, 2007